| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Operations
3 companies
Madhavan Balachandran is Director at STVN, with reported holdings spanning 3 companies. From January 2015 to June 2026, the filings on record show 0 open-market purchases and 14 sales. Madhavan Balachandran's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.7M at current prices.
Our model assigns Madhavan Balachandran a middling insider score of 51/100, based on 9 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -16.1%.
Madhavan Balachandran's largest disclosed position is in AMGN as EVP, Operations, worth about $10.7M. The AMGN filings lean toward selling, a net 51,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2020 | QURE Uniqure N.V. | Director | Sell | 807 | $62.20 | $50,195.40 | -11.8% | |
| Jan 28, 2019 | QURE Uniqure N.V. | Director | Sell | 1,210 | $31.31 | $37,885.10 | -15.1% | |
| May 4, 2016 | AMGN Amgen Inc | EVP, Operations | Sell | 30,000 | $154.12 | $4,623,624.00 | -34.9% | |
| May 7, 2015 | AMGN Amgen Inc | EVP, Operations | Sale+OE | 21,750 | $157.87 | $3,433,695.45 | -39.4% |